Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norberto Pantoja-Galicia

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Biopharmaceutical Statistics|August 23, 2016
Comparing diagnostic tests on benefit-riskGene Pennello, Norberto Pantoja-Galicia, Scott Evans
Muscle & Nerve|March 21, 2012
Application of futility analysis to refine jitter recordings in myasthenia gravisPushpa Narayanaswami, Norberto Pantoja-Galicia, Rebecca A Betensky, et al.
Radiation Research|June 18, 2021
Challenges and Strategies in the Development of Radiation Biodosimetry Tests for Patient ManagementMerriline Satyamitra, Francisca E Reyes Turcu, Norberto Pantoja-Galicia, et al.
Biostatistics & Epidemiology|October 3, 2022
Concordance Measures and Time-Dependent ROC MethodsNorberto Pantoja-Galicia, Olivia I Okereke, Deborah Blacker, et al.
Statistical Methods in Medical Research|April 8, 2015
Generalized linear mixed models for multi-reader multi-case studies of diagnostic testsWei Liu, Norberto Pantoja-Galicia, Bo Zhang, et al.
Alzheimer Disease and Associated Disorders|October 12, 2011
The SIST-M: predictive validity of a brief structured clinical dementia rating interviewOlivia I Okereke, Norberto Pantoja-Galicia, Maura Copeland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2016
Benefit-risk Evaluation for Diagnostics: A Framework (BED-FRAME)Scott R Evans, Gene Pennello, Norberto Pantoja-Galicia, et al.
Cancer Research Communications|July 2, 2026
Clinical validation of tissue and liquid companion diagnostics for BRAF V600E detection in non-small cell lung cancers from the PHAROS studyGregory J Riely, Jean-François Martini, Norberto Pantoja Galicia, et al.
Plos One|August 1, 2025
Analytical validation and sequencing coverage studies suggest that performance of a liquid biopsy assay is tumor agnostic (DNA-is-DNA)Wei Meng, Russell Petry, Norberto Pantoja Galicia, et al.
The Lancet. Infectious Diseases|March 30, 2025
Intention-to-diagnose and distinct research foci in diagnostic accuracy studiesScott R Evans, Gene Pennello, Shanshan Zhang, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Biopharmaceutical Statistics|August 23, 2016
Comparing diagnostic tests on benefit-riskGene Pennello, Norberto Pantoja-Galicia, Scott Evans
Muscle & Nerve|March 21, 2012
Application of futility analysis to refine jitter recordings in myasthenia gravisPushpa Narayanaswami, Norberto Pantoja-Galicia, Rebecca A Betensky, et al.
Radiation Research|June 18, 2021
Challenges and Strategies in the Development of Radiation Biodosimetry Tests for Patient ManagementMerriline Satyamitra, Francisca E Reyes Turcu, Norberto Pantoja-Galicia, et al.
Biostatistics & Epidemiology|October 3, 2022
Concordance Measures and Time-Dependent ROC MethodsNorberto Pantoja-Galicia, Olivia I Okereke, Deborah Blacker, et al.
Statistical Methods in Medical Research|April 8, 2015
Generalized linear mixed models for multi-reader multi-case studies of diagnostic testsWei Liu, Norberto Pantoja-Galicia, Bo Zhang, et al.
Alzheimer Disease and Associated Disorders|October 12, 2011
The SIST-M: predictive validity of a brief structured clinical dementia rating interviewOlivia I Okereke, Norberto Pantoja-Galicia, Maura Copeland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2016
Benefit-risk Evaluation for Diagnostics: A Framework (BED-FRAME)Scott R Evans, Gene Pennello, Norberto Pantoja-Galicia, et al.
Cancer Research Communications|July 2, 2026
Clinical validation of tissue and liquid companion diagnostics for BRAF V600E detection in non-small cell lung cancers from the PHAROS studyGregory J Riely, Jean-François Martini, Norberto Pantoja Galicia, et al.
Plos One|August 1, 2025
Analytical validation and sequencing coverage studies suggest that performance of a liquid biopsy assay is tumor agnostic (DNA-is-DNA)Wei Meng, Russell Petry, Norberto Pantoja Galicia, et al.
The Lancet. Infectious Diseases|March 30, 2025
Intention-to-diagnose and distinct research foci in diagnostic accuracy studiesScott R Evans, Gene Pennello, Shanshan Zhang, et al.
Pageof 1